These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 11181499)

  • 41. Simultaneous determination of HIV protease inhibitors amprenavir, atazanavir, indinavir, lopinavir, nelfinavir, ritonavir and saquinavir in human plasma by high-performance liquid chromatography-tandem mass spectrometry.
    Dickinson L; Robinson L; Tjia J; Khoo S; Back D
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Dec; 829(1-2):82-90. PubMed ID: 16226495
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Relationships between binding of benzodiazepines to alpha-1-acid glycoprotein and human serum albumin and their retention on the protein and octadecylsilane columns.
    Sadlej-Sosnowska N
    Biomed Chromatogr; 1995; 9(3):150-1. PubMed ID: 7655304
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Plasma binding of an alpha-blocking agent, nicergoline--affinity for serum albumin and native and modified alpha 1-acid glycoprotein.
    Robert L; Migne J; Santonja R; Zini R; Schmid K; Tillement JP
    Int J Clin Pharmacol Ther Toxicol; 1983 Jun; 21(6):271-6. PubMed ID: 6885199
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A pharmacokinetic study of intermittent rifabutin dosing with a combination of ritonavir and saquinavir in patients infected with human immunodeficiency virus.
    Gallicano K; Khaliq Y; Carignan G; Tseng A; Walmsley S; Cameron DW
    Clin Pharmacol Ther; 2001 Aug; 70(2):149-58. PubMed ID: 11503009
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Rapid quantification of HIV protease inhibitors in human plasma by high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry.
    Crommentuyn KM; Rosing H; Nan-Offeringa LG; Hillebrand MJ; Huitema AD; Beijnen JH
    J Mass Spectrom; 2003 Feb; 38(2):157-66. PubMed ID: 12577282
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Utility of unbound plasma drug levels and P-glycoprotein transport data in prediction of central nervous system exposure.
    He H; Lyons KA; Shen X; Yao Z; Bleasby K; Chan G; Hafey M; Li X; Xu S; Salituro GM; Cohen LH; Tang W
    Xenobiotica; 2009 Sep; 39(9):687-93. PubMed ID: 19569734
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Serum binding of ketoconazole in health and disease.
    Martínez-Jordá R; Rodriguez-Sasiain JM; Suárez E; Calvo R
    Int J Clin Pharmacol Res; 1990; 10(5):271-6. PubMed ID: 2079384
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Enantioselective gallopamil protein binding.
    Gross AS; Eser C; Mikus G; Eichelbaum M
    Chirality; 1993; 5(6):414-8. PubMed ID: 8398599
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Binding of taxol to human plasma, albumin and alpha 1-acid glycoprotein.
    Kumar GN; Walle UK; Bhalla KN; Walle T
    Res Commun Chem Pathol Pharmacol; 1993 Jun; 80(3):337-44. PubMed ID: 8102493
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Alterations in serum protein binding and pharmacokinetics of l-propranolol in the rat elicited by the presence of an indwelling venous catheter.
    Terao N; Shen DD
    J Pharmacol Exp Ther; 1983 Nov; 227(2):369-75. PubMed ID: 6631719
    [TBL] [Abstract][Full Text] [Related]  

  • 51. HPLC quantification of the HIV-1 protease inhibitor saquinavir in brain and testis of mice.
    Mudigonda K; Jukanti R; Apte SS; Ajjala DR; Shrivastava W; Kandikere VN; Nirogi RV
    Biomed Chromatogr; 2006 Oct; 20(10):1028-32. PubMed ID: 16506264
    [TBL] [Abstract][Full Text] [Related]  

  • 52. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA
    Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Protein binding of itraconazole and fluconazole in patients with cancer.
    Arredondo G; Calvo R; Marcos F; Martínez-Jordá R; Suarez E
    Int J Clin Pharmacol Ther; 1995 Aug; 33(8):449-52. PubMed ID: 8556224
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vivo effect of alpha(1)-acid glycoprotein on pharmacokinetics of amprenavir, a human immunodeficiency virus protease inhibitor.
    Sadler BM; Gillotin C; Lou Y; Stein DS
    Antimicrob Agents Chemother; 2001 Mar; 45(3):852-6. PubMed ID: 11181371
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Investigation of high-throughput ultrafiltration for the determination of an unbound compound in human plasma using liquid chromatography and tandem mass spectrometry with electrospray ionization.
    Zhang J; Musson DG
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Oct; 843(1):47-56. PubMed ID: 16815762
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Contribution of plasma proteins, albumin and alpha 1-acid glycoprotein, to pharmacokinetics of a multi-targeted receptor tyrosine kinase inhibitor, sunitinib, in analbuminemic rats.
    Toyama Y; Ueyama J; Nomura H; Tsukiyama I; Saito H; Hisada T; Matsuura K; Hasegawa T
    Anticancer Res; 2014 May; 34(5):2283-9. PubMed ID: 24778032
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Gender differences in the metabolism and pharmacokinetics of the experimental anticancer agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA).
    Zhou S; Kestell P; Tingle MD; Paxton JW
    Cancer Chemother Pharmacol; 2002 Feb; 49(2):126-32. PubMed ID: 11862426
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Development and validation of a reversed-phase liquid chromatographic method with fluorescence detection for the study of Saquinavir pharmacokinetics in rat plasma.
    Pathak SM; Kumar AR; Subramanian G; Udupa N
    Anal Chim Acta; 2007 Jul; 594(2):248-56. PubMed ID: 17586122
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dosage plan of a flurbiprofen injection product using inhibition of protein binding by lipid emulsion in rats.
    Ogata K; Takamura N; Tokunaga J; Kawai K; Arimori K; Higuchi S
    J Pharm Pharmacol; 2008 Jan; 60(1):15-20. PubMed ID: 18088500
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intracellular and plasma pharmacokinetics of nelfinavir and M8 in HIV-infected patients: relationship with P-glycoprotein expression.
    Ford J; Cornforth D; Hoggard PG; Cuthbertson Z; Meaden ER; Williams I; Johnson M; Daniels E; Hsyu P; Back DJ; Khoo SH
    Antivir Ther; 2004 Feb; 9(1):77-84. PubMed ID: 15040539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.